Product Wiki · Recalls · EU Safety Gate (RAPEX)

Skoczek piesek — recall A12/01303/24

EU Safety Gate (RAPEX) · Poland · 2024-05-24 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/01303/24
Date of alert
2024-05-24
Country / jurisdiction
Poland
Risk level
Serious risk
Risk type
Chemical
Product category
Toys
Product type
Inflatable toy
Barcode (EAN/GTIN)
5902553818550
Reported risk: Zabawka ma nadmierną ilość ftalanu diizobutylu (DIBP) (zmierzona wartość do 5,8% wagowych). Ten ftalan może zaszkodzić zdrowiu dzieci, powodując możliwe uszkodzenie układu rozrodczego. Produkt nie spełnia wymogów rozporządzenia REACH.
Action taken by the authority
Type of economic operator taking notified measure
Importer
Category of measure
Warning consumers of the risks
Date of entry into force
12/04/2024
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Skoczek piesek

Risk Description (original English): The toy has an excessive amount of diisobutyl phthalate (DIBP) (measured value up to 5.8% by weight). This phthalate may harm the health of children, causing possible damage to the reproductive system.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10013097

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.